Biopartners GmbH and LG Life Sciences Ltd (LGLS) Present Positive Phase 3, Twenty-Four Months Efficacy and Safety Data for Sustained Release Recombinant Human Growth Hormone (LB03002) Given to Children with Growth Hormone De